BREAKING NEWS 🚀🇺🇸🤩
Technoclone & DiaPharma is pleased to announce that the US Food and Drug Administration (#FDA) granted #DeNovo marketing authorization for #Technozym #ADAMTS13 Activity ELISA. This is the first ADAMTS13 activity test authorized by the FDA.